- Published at
- by manilatimes.net
mixed
mixed
Upstream Bio Appoints Stacy Price as Chief Technology Officer
**media[631366]**
News for ZIOPHARM Oncology, Inc. (ZIOP)
- Published at
- by gurufocus.com
positivepositiveSilence Therapeutics Welcomes Tim McInerney to Board of Directors
Silence Therapeutics plc, Nasdaq: SLN (”Silence” or ”the Company”), a global clinical-stage company developing novel siRNA (short interfering RNA) ther- Published at
- by gurufocus.com
mixedmixed- Published at
- by investing.com
positivepositiveTCRT stock touches 52-week low at $1.92 amid market challenges By Investing.com
TCRT stock touches 52-week low at $1.92 amid market challenges- Published at
- by investing.com
positivepositiveTCRT stock touches 52-week low at $2.06 amid market challenges By Investing.com
TCRT stock touches 52-week low at $2.06 amid market challenges- Published at
- by investing.com
negativenegativeTCRT stock touches 52-week low at $2.1 amid market challenges By Investing.com
TCRT stock touches 52-week low at $2.1 amid market challenges- Published at
- by investing.com
neutralneutralTCRT stock touches 52-week low at $2.28 amid market challenges By Investing.com
TCRT stock touches 52-week low at $2.28 amid market challenges- Published at
- by investing.com
neutralneutralAlaunos Therapeutics announces 1-for-10 reverse stock split By Investing.com
Alaunos Therapeutics announces 1-for-10 reverse stock split- Published at
- by globenewswire.com
mixedmixedTScan Therapeutics Appoints Seasoned Industry Executive Jason A. Amello as Chief Financial Officer
WALTHAM, Mass., Jan. 29, 2024 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the...- Published at
- by globenewswire.com
mixedmixedNeoantigen Cancer Vaccine Market Size is Projected to Reach $1.38 billion by 2030: Straits Research
The growth of the market for Neoantigen cancer vaccines is primarily attributable to rapid technological advancements and improvements in the healthcare...- Published at
- by prnewswire.com
mixedmixedNatural Killer Cells Therapeutics Market Analysis and Industry Forecast Report 2023: Focus on Cancer Immunotherapy, Infectious Diseases and Autoimmune Disorders
/PRNewswire/ -- The "Natural Killer Cells Therapeutics Market: Global Opportunity Analysis and Industry Forecast, 2027" report has been added to...- Published at
- by globenewswire.com
mixedmixedSpero Therapeutics Appoints Sath Shukla as President & Chief Executive Officer
Sath Shukla, current Spero Chief Financial Officer, will bring more than 20 years of strategic and financial leadership to the role of CEO, to be effective...- Published at
- by globenewswire.com
neutralneutralInvivyd Appoints Robert Allen as Chief Scientific Officer and Stacy Price as Chief Technology and Manufacturing Officer
WALTHAM, Mass., April 12, 2023 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a clinical-stage biopharmaceutical company on a mission to protect the...- Published at
- by marketscreener.com
mixedmixedEnlivex Therapeutics : NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS - Form 6-K
NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS To be held on November 17, 2022 Dear Shareholder: We cordially invite you to attend the Annual... | October 5, 2022- Published at
- by etfdailynews.com
mixedmixedEquities Research Analysts’ Downgrades for June 1st (AOMR, CFR, CTT, CYPXF, DIBS, EMBVF, EQ, ERF, FPI, FTS)
Read Equities Research Analysts’ Downgrades for June 1st (AOMR, CFR, CTT, CYPXF, DIBS, EMBVF, EQ, ERF, FPI, FTS) at ETF Daily NewsVRRMWVRRMTSGTYTSGTFSTLA.PASTLASPXSYSPXSFSPX.LSPFR-UNSPFRSBTXPTGEFPRTGPGENPFBCPEDOPBKOBNKNSA-PANSAMITEYMITEFMDTFTSFPIERFDIBSCF.TOCCORFAOMR8802.T600600.SS0168.HKZIOPWFCWEBRVLOVCVCWVCVCUVCVCVBTXUTLUSDPUBSN.MXUBSGEE.SWUBSGE.SWUBSG34.SAUBSG.SWUBSTSCBPTSCAPTSCTRSTTHMAWTHMAUTHMASMBKSHBISGML.VSFBSSEESBSWRYAMRYRRBIREEPULMPSOPPBBPEBOPEBCOSCRLTUMLOVEJPMMLJPMHZON-WTHZAC-WTHZAC-UNHZACGMIIWGMIIUGMIICYPXFCTTCFR0QKU.L0JVB.LYYTWOUTPXTPLKIMBERB.MXKIMBERA.MXKCDMYKCDMFHTGCGSGI34.SAGS.MXGS.BAGSGOS.DEBCY.DEBCSN.MXBCS.BABCSBCLYFBARC.L- Published at
- by etfdailynews.com
mixedmixedAinos (OTCMKTS:AIMD) versus Alaunos Therapeutics (NASDAQ:TCRT) Critical Review
Read Ainos (OTCMKTS:AIMD) versus Alaunos Therapeutics (NASDAQ:TCRT) Critical Review at ETF Daily News- Published at
- by marketscreener.com
mixedmixedEnlivex Therapeutics : NOTICE OF ANNUAL AND EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS ON (Form 6-K)
NOTICE OF ANNUAL AND EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS ON NOVEMBER 4, 2021 Notice is hereby given that an Annual and... | September 30, 2021- Published at
- by markets.businessinsider.com
mixedmixed3 Penny Stocks Insiders Are Buying
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interest...- Published at
- by benzinga.com
mixedmixedStocks That Hit 52-Week Lows On Monday
On Monday morning, 207 companies hit new 52-week lows. Intriguing Points: The largest company in terms of market cap to set a new 52-week low was ...VMEOOSCRNATKPTIEFOIEARAXDXAGRXACXPACADWDHVECTTLSATLMDTLGTTARASDCSCPSSBBPRMTIQSPRLBPIXYPHGNVROMSGMMMATMDVLMDGLLTCHLMNLLIVKJUPWJRJCHOTHGANXFLXNEVFMEVERESGCEMELOXEHTHDMDGLYCTOSCRVSBXRXBQAXSMAVROATNXATHMARNAAPPHZIOPYYYSGYJVYNTVSTAVLDRTXMDTRKATMCITASTSPOTD.BASPOKSNTGSLQTSKLZSAMRMOREDURAASQTWOPTRAPSFEPOSHPHIOPALIOTICORTXNVTANKTRNEWMNSOMFMCWMCRBLZLOTZLIQTLGVNKURAKROSKPLTIOIMRAIMCRIKTIFRXHYMCHUYAHUIZHRTXHOOKHERAHARPHAPPGOGNPXGNCAGMTXGLTOFMCEYEGETONEPZMENVBDNMRDFFNDCPHCSPRCOECJJDCGRNCANGBZUNBMEABLSABLCTATXIATERATAIARDXARAVAKYAAKUAEI0UNL.L- Published at
- by markets.businessinsider.com
mixedmixedThe Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Au...ZIVOPFED.BAPFECL.SNPFE.MXPFE.DEPFEMDNA.TOMDNAJAZZHARPFUSNCODXCAPRBNTXN.MXBNTX0A50.L0A3M.LZLDPFZIOPZGNXZEALXCURVYNEVYGR.MXVYGRVECTTXMDTRVNTRIL.TOTRILTLGTTFFPTARASPRBSONNRVMDRPIDRMTIPROGPRAXPMCBDPMCBPBLAPASGORTXNKTRNBIXMRNA.MXMRNAMNOVMBRXM1RN34.SALVTXLUMOLMNLKRONKPTIKNSAJAGXITRMIRWDIRTCINCYINABIMRAIKTI1NC34.SAHRTXHOTHHOOKHBIOGTBPGRFSGRFPN.MXGRF.MCGIS.DEGILDD.BAGILD.MXGILDGIKLYGIFOFGIFLFFMTXFLXNFGEN.MXFGENEYEGEWTXEPZMENSCWENSCDVAXDRNADMACCTMXCLRBCELUBXRXBUWA.DEBPTHBMEABIOLBIO-BBIOBDSXBAX.MXBAXAYTUAXSMATAIARDSALLOALKSALIMAKROAGLEACHLACAD4875.T0UNL.L0QK8.L0M3O.L0K6R.L0J9P.L0J4V.L0IL8.L0IDA.L0HKF.L0A8M.L0A7L.L0A4W.L0A45.LSESNJNJINVADJNJ3.BADJNJ2.BAARNAAPREABVC0S54.L